Insider · CIK 0001924892
Romin Nabiey
Files at GDRX (GoodRx Holdings, Inc.). First filing Aug 14, 2024, latest Aug 14, 2024.
In brief
Romin Nabiey files SEC Form 4 as officer at GDRX (GoodRx Holdings, Inc.). Since Aug 14, 2024, Romin Nabiey has reported 0 open-market buys worth $0 and 1 open-market sell worth $535k, the latest filed on Aug 14, 2024.
A track record needs three past buys with six months of prices behind them; Romin Nabiey has 0, so none is measured yet.
The newest scored trade: sold $535k of GDRX on Aug 12, 2024, filed Aug 14, 2024, scored 53 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GDRX: GoodRx Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | GDRXsell GoodRx Holdings, Inc. | $535k 79,000 shares | -55% | +53% from low-25% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 12, 2024 | GDRX GOODRX HOLDINGS, INC. | 79,000 0.08% of outstanding | $535k | Aug 12, 2024 | none |
Transactions
The newest 50 of 120 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 8, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +10,201 | - | - | 185,949 | Mar 9, 2026 |
| Mar 8, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -4,201 | $2.28 | $9,578 | 181,748 | Mar 9, 2026 |
| Mar 8, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +2,233 | - | - | 183,981 | Mar 9, 2026 |
| Mar 8, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -920 | $2.28 | $2,098 | 183,061 | Mar 9, 2026 |
| Mar 8, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -10,201 | $0.00 | $0 | 20,402 | Mar 9, 2026 |
| Mar 8, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -2,233 | $0.00 | $0 | 17,858 | Mar 9, 2026 |
| Mar 3, 2026 | GDRX GoodRx Holdings, Inc. | AGrant or award Restricted Stock Unitderivative | +108,189 | $0.00 | $0 | 108,189 | Mar 5, 2026 |
| Feb 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +4,804 | - | - | 177,727 | Feb 17, 2026 |
| Feb 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -1,979 | $2.18 | $4,314 | 175,748 | Feb 17, 2026 |
| Feb 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -4,804 | $0.00 | $0 | 57,650 | Feb 17, 2026 |
| Feb 8, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +12,663 | - | - | 178,138 | Feb 9, 2026 |
| Feb 8, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -5,215 | $2.44 | $13k | 172,923 | Feb 9, 2026 |
| Feb 8, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -12,663 | $0.00 | $0 | 63,314 | Feb 9, 2026 |
| Dec 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +10,200 | - | - | 167,692 | Dec 8, 2025 |
| Dec 8, 2025 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -3,650 | $2.71 | $9,892 | 164,042 | Dec 8, 2025 |
| Dec 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +2,232 | - | - | 166,274 | Dec 8, 2025 |
| Dec 8, 2025 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -799 | $2.71 | $2,165 | 165,475 | Dec 8, 2025 |
| Dec 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -10,200 | $0.00 | $0 | 30,603 | Dec 8, 2025 |
| Dec 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -2,232 | $0.00 | $0 | 20,091 | Dec 8, 2025 |
| Nov 15, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +4,804 | - | - | 158,211 | Nov 17, 2025 |
| Nov 15, 2025 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -1,719 | $2.97 | $5,105 | 156,492 | Nov 17, 2025 |
| Nov 15, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -4,804 | $0.00 | $0 | 62,454 | Nov 17, 2025 |
| Nov 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +12,662 | - | - | 157,938 | Nov 10, 2025 |
| Nov 8, 2025 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -4,531 | $3.11 | $14k | 153,407 | Nov 10, 2025 |
| Nov 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -12,662 | $0.00 | $0 | 75,977 | Nov 10, 2025 |
| Sep 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +10,201 | - | - | 147,493 | Sep 8, 2025 |
| Sep 8, 2025 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -3,650 | $4.00 | $15k | 143,843 | Sep 8, 2025 |
| Sep 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +2,232 | - | - | 146,075 | Sep 8, 2025 |
| Sep 8, 2025 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -799 | $4.00 | $3,196 | 145,276 | Sep 8, 2025 |
| Sep 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -10,201 | $0.00 | $0 | 40,803 | Sep 8, 2025 |
| Sep 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -2,232 | $0.00 | $0 | 22,323 | Sep 8, 2025 |
| Aug 15, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +4,804 | - | - | 139,011 | Aug 15, 2025 |
| Aug 15, 2025 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -1,719 | $3.54 | $6,085 | 137,292 | Aug 15, 2025 |
| Aug 15, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -4,804 | $0.00 | $0 | 67,258 | Aug 15, 2025 |
| Aug 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +12,663 | - | - | 138,738 | Aug 8, 2025 |
| Aug 8, 2025 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -4,531 | $3.47 | $16k | 134,207 | Aug 8, 2025 |
| Aug 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -12,663 | $0.00 | $0 | 88,639 | Aug 8, 2025 |
| Jun 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +10,201 | - | - | 128,292 | Jun 9, 2025 |
| Jun 8, 2025 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -3,650 | $4.08 | $15k | 124,642 | Jun 9, 2025 |
| Jun 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +2,232 | - | - | 126,874 | Jun 9, 2025 |
| Jun 8, 2025 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -799 | $4.08 | $3,260 | 126,075 | Jun 9, 2025 |
| Jun 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -10,201 | $0.00 | $0 | 51,004 | Jun 9, 2025 |
| Jun 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -2,232 | $0.00 | $0 | 24,555 | Jun 9, 2025 |
| May 15, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +4,804 | - | - | 119,810 | May 15, 2025 |
| May 15, 2025 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -1,719 | $4.27 | $7,340 | 118,091 | May 15, 2025 |
| May 15, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -4,804 | $0.00 | $0 | 72,062 | May 15, 2025 |
| May 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +12,663 | - | - | 119,537 | May 8, 2025 |
| May 8, 2025 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -4,531 | $3.79 | $17k | 115,006 | May 8, 2025 |
| May 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -12,663 | $0.00 | $0 | 101,302 | May 8, 2025 |
| Mar 8, 2025 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +10,201 | - | - | 109,640 | Mar 10, 2025 |
Questions about Romin Nabiey
Answered from the filings on this page, as of the latest one.
Is Romin Nabiey buying or selling?
Not in the last 12 months. Romin Nabiey's latest open-market trade on SEC Form 4 was sold $535k of GDRX on Aug 12, 2024.
How did Romin Nabiey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Romin Nabiey has 0.
Where does Romin Nabiey file Form 4?
Romin Nabiey has filed Form 4 at GDRX (GoodRx Holdings, Inc.) as Chief Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.